Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research

Contract Research

Tiziana acquires bio-repository from Shardna By PBR Staff Writer
UK-based clinical stage biotechnology company Tiziana Life Sciences has acquired the genetic data of about 13,000 people from the Ogliastra region of Sardinia.
Contract Research & Services > Contract Research > News
Juno Therapeutics acquires Boston-based RedoxTherapies By PBR Staff Writer
Biopharmaceutical firm Juno Therapeutics has acquired privately held Boston-based RedoxTherapies.
Contract Research & Services > Contract Research > News Eli Lilly, Boehringer Ingelheim form clinical trial partnership in metastatic breast cancer By PBR Staff Writer
Pharmaceutical giants Eli Lilly and Company and Boehringer Ingelheim have announced a new partnership focused on metastatic breast cancer (mBC).
Contract Research & Services > Contract Research > News
See more Contract Research news

Latest Contract Research News and Insight

View all Contract Research news or find news targeted to your interests
Eli Lilly, Boehringer Ingelheim form clinical trial partnership in metastatic breast cancer
By PBR Staff Writer
Pharmaceutical giants Eli Lilly and Company and Boehringer Ingelheim have announced a new partnership focused on metastatic breast cancer (mBC).
Contract Research & Services > Contract Research > News
Molnar-Institute: Benefits and Capabilities of DryLab®
| By Molnár-Institute
Anybody working in the realm of HPLC who wishes to economize the resources spent developing and running methods can benefit from the advantages offered by DryLab®.
Contract Research & Services > Contract Research > White Papers
DryLab4 Training Course and Quality by Design Principles Course
The Molnár-Institute is pleased to welcome our attendees from around the world to our DryLab4 Training Course and Quality by Design Principles Course this fall, from Monday September 26th to Wednesday, September 28th. The course will be hosted at the Maritim proArte Hotel in central Berlin.
Contract Research & Services > Contract Research > Press Releases
Grant funding secured to explore Midatech's gold nanoparticle technology in immunotherapy
Midatech Pharma announced that its research collaboration with Cardiff University in autoimmune therapies has received a two-year funding grant from JDRF (Juvenile Diabetes Research Foundation), for a project entitled "Gold nanoparticles coupled with selective PAMP ligands to deliver antigen specific immunotherapy" in diabetes, the commonest autoimmune disease worldwide.
Contract Research & Services > Contract Research > News
BMS, PsiOxus Therapeutics to study immuno-oncology combination
By PBR Staff Writer
Bristol-Myers Squibb (BMS) and UK-based PsiOxus Therapeutics have agreed to work together on a new combination therapy targeting various tumor types in late-stage cancer patients.
Contract Research & Services > Contract Research > News
Novo Nordisk Pharmatech Now Distributing with Brenntag Specialities
Novo Nordisk Pharmatech A/S and Brenntag Specialties, Inc. (BSI) have entered into a distribution agreement for Pharmaceutical Grade Quaternary Ammonium Compounds into the Pharmaceutical, Over-the-Counter (OTC), and Personal Care Markets in the United States and Puerto Rico.
Contract Research & Services > Contract Research > Press Releases
TB Alliance, Takeda partner to investigate novel compounds for tuberculosis treatment
The Global Alliance for TB Drug Development (TB Alliance) and Takeda Pharmaceutical Company have entered into an agreement that further explores hits generated from a high-throughput screening program conducted to find novel compounds to improve treatment of tuberculosis (TB).
Contract Research & Services > Contract Research > News
Genentech, Epizyme to assess anti-cancer effects of tazemetostat/Tecentriq combination
By PBR Staff Writer
Roche's subsidiary Genentech and biopharmaceutical firm Epizyme will collaborate on a phase 1b clinical trial to evaluate the combination of tazemetostat and Tecentriq for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL).
Contract Research & Services > Contract Research > News
ORIG3N, Kangstem Biotech collaborate to study neural stem cells
ORIG3N and Kangstem Biotech have started a scientific collaboration to study the utility of induced neural stem cells (iNSC) in disease modeling.
Contract Research & Services > Contract Research > News
Arkin Holdings, Phoenix Group sign collaboration deal to invest $60m in pharma and biotech companies
Phoenix Group and Arkin Holdings have signed a Strategic Collaboration Agreement for investment in pharma and biotech companies, for a total of approximately $60 Million (with an option to increase the investment in the future).
Contract Research & Services > Contract Research > News
View all Contract Research news or find news targeted to your interests